7,549.94

+173.08

+2.35%

52,389.75

+1,104.02

+2.15%

25,253.14

+673.74

+2.74%

2,840.81

+86.71

+3.15%

4.8640

+0.0050

+0.10%

19.92

-5.72

-22.31%

4,148.40

+33.90

+0.82%

75,273.83

+517.30

+0.69%

Crude Oil Dec 26

86.48

-0.37

-0.43%

US Private Equity

10,772.76

+11.86

+0.11%

NasdaqCM - Delayed Quote USD

Eloxx Pharmaceuticals, Inc. (ELOX)

13.51 +1.07 (+8.60%)

At close: November 9 at 4:00:00 PM EST

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

Eloxx Pharmaceuticals to Present at the 3rd Annual Guggenheim Healthcare Innovation Conference

PR Newswire 7d ago

ELOX
+8.11%
Eloxx Pharmaceuticals Announces FDA Clearance of Investigational New Drug Application for Exaluren in Nonsense-Mutation ADPKD

PR Newswire 11d ago

ELOX
+8.11%
Eloxx Pharmaceuticals Finalizes 52-Week Phase 2 EXPRESS Study Design in Nonsense-Mutation ADPKD and Appoints T.R. Srinivas, M.D., Chief Medical Officer

PR Newswire 20d ago

ELOX
+8.11%
NVS
Eloxx Pharmaceuticals Appoints Biopharmaceutical Industry Veteran Geno Germano to its Board of Directors

PR Newswire 21d ago

ELOX
+8.11%
PFE

ENTX
Eloxx Pharmaceuticals Announces First Patients Dosed in Phase 2b EXACT Study of Exaluren in Nonsense Mutation Alport Syndrome

PR Newswire 1mo ago

ELOX
+8.11%
Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

PR Newswire 2mo ago

ELOX
+8.11%
^IXIC
Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq

PR Newswire 4mo ago

ELOX
+8.11%

Performance Overview

Return	ELOX	S&P 500 (^GSPC)
YTD	+35.10%	+10.29%
1-Year	+35.10%	+12.20%
3-Year	+35.10%	+73.67%

Mobilize your Website

View Site in Mobile | Classic

Share by: